跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HEMLIBRA emicizumab (rch) 30 mg/1 mL solution for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
HEMLIBRA emicizumab (rch) 30 mg/1 mL solution for injection vial
Approved
STANDARD
HEMLIBRA emicizumab (rch) 30 mg/1 mL solution for injection vial
Roche Products Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
964e2e61be8a6cc5
Company
Roche Products Pty Ltd
Type
Standard
Approval Details
Approval Id
964e2e61be8a6cc5
Product Name
HEMLIBRA emicizumab (rch) 30 mg/1 mL solution for injection vial
Artg Id
293761
Artg Name
HEMLIBRA emicizumab (rch) 30 mg/1 mL solution for injection vial
Sponsor
Roche Products Pty Ltd
Company Detail Path
/organization/roche-products-pty-ltd
Artg Date
2018-02-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/189554dd930fa9ab5d1b301d9927ad05.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/c81694eba78fef46fd3e99fda5496edb.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
964e2e61be8a6cc5
Type
Standard
Back to TGA Approvals